Crossmark

Podocalyxin-like protein as a predictive biomarker for benefit of neoadjuvant chemotherapy in resectable gastric and esophageal adenocarcinoma

Crossref DOI link: https://doi.org/10.1186/s12967-018-1668-3

Published Online: 2018-10-24

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Borg, David https://orcid.org/0000-0001-9461-7391
Larsson, Anna H.

Hedner, Charlotta

Nodin, Björn

Johnsson, Anders

Jirström, Karin
Funding

Funding for this research was provided by:

Cancerfonden

Swedish Government Grant for Clinical Research

Fru Berta Kamprads Stiftelse

Swedish Society for Gastrointestinal Oncology

Lund University Faculty of Medicine and Skåne University Hospital Funds and Donations
License Information

Text and Data Mining valid from 2018-10-24
More Information

Article History

Received: 4 May 2018

Accepted: 17 October 2018

First Online: 24 October 2018